SCHEMBL4873258

SCHEMBL4873258

N#[Pt]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1513167 0.58
SCHEMBL30087555 0.58
SCHEMBL29377725 0.58
SCHEMBL7590436 0.58
SCHEMBL8433806 0.58
SCHEMBL29439098 0.58
SCHEMBL30462986 0.58
SCHEMBL29378423 0.58
SCHEMBL19781 0.58
SCHEMBL28113322 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10377784-B2 Design, synthesis, and biological activity of platinum-benz[c]acridine hybrid agents and methods associated therewith WAKE FOREST UNIVERSITY (US) 2019-08-13 US claimed
US-20180319832-A1 Design, Synthesis, and Biological Activity of Platinum-benz[c]acridine Hybrid Agents and Methods Associated Therewith WAKE FOREST UNIVERSITY (US) 2018-11-08 US claimed
EP-3104862-A1 DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF PLATINUM-BENZ[C]ACRIDINE HYBRID AGENTS AND METHODS ASSOCIATED THEREWITH Wake Forest University (US) 2016-12-21 EP disclosed
WO-2015142684-A1 DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF PLATINUM-BENZ[C]ACRIDINE HYBRID AGENTS AND METHODS ASSOCIATED THEREWITH WAKE FOREST UNIVERSITY (US) 2015-09-24 WO disclosed
US-20080036373-A1 Platinum complex and light-emitting device TAKASAGO INTERNATIONAL CORPORATION 2008-02-14 US disclosed
US-20060202197-A1 Platinum complex and light-emitting device TAKASAGO INTERNATIONAL CORPORATION 2006-09-14 US disclosed